Burden of Undiagnosed Hypertension among Adults in Urban Communities of Southwest Ethiopia.
Ethiopia
Jimma town
adult
burden
hypertension
risk
undiagnosed
Journal
Integrated blood pressure control
ISSN: 1178-7104
Titre abrégé: Integr Blood Press Control
Pays: New Zealand
ID NLM: 101562709
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
12
2020
accepted:
26
04
2021
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
1
6
2021
Statut:
epublish
Résumé
Hypertension (HTN) is the leading risk factor for mortality due to cardiovascular diseases, it accounts for 7% of global disability adjusted life years. In 2015, it was estimated that around 1.13 billion adults had HTN globally with a high prevalence in low and middle-income countries where the health system is weak to diagnose, treat, and control HTN. Most people with HTN are asymptomatic and go undiagnosed for years. Therefore, the aim of this study was to assess the burden of undiagnosed HTN among adults in urban communities of Southwest Ethiopia. A community-based cross-sectional study involving 915 adults from June 17 to July 27, 2019 was performed. WHO STEPS questionnaire was used to collect data, and the collected data were entered using Epi Data version 3.1and analyzed using SPSS version 20, respectively. Binary logistic regression was used to check for a possible association between outcome and independent factors. Undiagnosed HTN in the study area was 21.2% (194). Age (AOR=1.04, 95% CI=1.02-1.05), BMI with overweight (AOR=2.52, 95% CI=1.35-4.71), triglyceride (AOR=1.83, 95% CI=1.29-2.59), and waist to hip ratio (AOR=1.62, 95% CI=1.03-2.54) were factors significantly associated with HTN. As compared to studies performed before, the risk of undiagnosed HTN in the current study was high. Age, BMI, triglyceride, and waist to hip ratios were found to be the significant factors for it. Preventing the risk factors and screening of HTN should be promoted for early detection, prevention, and treatment of the burden of the disease on the population.
Sections du résumé
BACKGROUND
BACKGROUND
Hypertension (HTN) is the leading risk factor for mortality due to cardiovascular diseases, it accounts for 7% of global disability adjusted life years. In 2015, it was estimated that around 1.13 billion adults had HTN globally with a high prevalence in low and middle-income countries where the health system is weak to diagnose, treat, and control HTN. Most people with HTN are asymptomatic and go undiagnosed for years. Therefore, the aim of this study was to assess the burden of undiagnosed HTN among adults in urban communities of Southwest Ethiopia.
METHODS
METHODS
A community-based cross-sectional study involving 915 adults from June 17 to July 27, 2019 was performed. WHO STEPS questionnaire was used to collect data, and the collected data were entered using Epi Data version 3.1and analyzed using SPSS version 20, respectively. Binary logistic regression was used to check for a possible association between outcome and independent factors.
RESULTS
RESULTS
Undiagnosed HTN in the study area was 21.2% (194). Age (AOR=1.04, 95% CI=1.02-1.05), BMI with overweight (AOR=2.52, 95% CI=1.35-4.71), triglyceride (AOR=1.83, 95% CI=1.29-2.59), and waist to hip ratio (AOR=1.62, 95% CI=1.03-2.54) were factors significantly associated with HTN.
CONCLUSION
CONCLUSIONS
As compared to studies performed before, the risk of undiagnosed HTN in the current study was high. Age, BMI, triglyceride, and waist to hip ratios were found to be the significant factors for it. Preventing the risk factors and screening of HTN should be promoted for early detection, prevention, and treatment of the burden of the disease on the population.
Identifiants
pubmed: 34054307
doi: 10.2147/IBPC.S293251
pii: 293251
pmc: PMC8153066
doi:
Types de publication
Journal Article
Langues
eng
Pagination
69-76Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021 Mogas et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1395-1410
pubmed: 30251346
Hypertension. 2015 Feb;65(2):291-8
pubmed: 25385758
Ethiop J Health Sci. 2014 Jan;24(1):21-6
pubmed: 24591795
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Public Health Rev. 2015 Dec 9;36:14
pubmed: 29450042
Hypertension. 2004 May;43(5):1017-22
pubmed: 15037552
JAMA. 2003 May 21;289(19):2560-72
pubmed: 12748199
Int J Public Health. 2014 Oct;59(5):759-67
pubmed: 24942996
J Hypertens. 2009 Jul;27(7):1472-7
pubmed: 19474763
Lancet. 2017 Dec 9;390(10112):2549-2558
pubmed: 29102084
Hypertension. 2007 Dec;50(6):1012-8
pubmed: 17954720
Pan Afr Med J. 2013 Oct 05;16:38
pubmed: 24570798
Jpn Circ J. 1986 Dec;50(12):1191-200
pubmed: 3469420
Heliyon. 2020 Jan 06;6(1):e03147
pubmed: 32042945
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1261-1264
pubmed: 27855138
Int J Environ Res Public Health. 2019 Apr 04;16(7):
pubmed: 30987361
Diabetes Metab Syndr Obes. 2020 Aug 19;13:2925-2933
pubmed: 32904561
Cardiopulm Phys Ther J. 2011 Jun;22(2):5-12
pubmed: 21637392
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47
pubmed: 24842598
BMC Public Health. 2015 Dec 05;15:1211
pubmed: 26637309
Int J Hypertens. 2017;2017:5491838
pubmed: 29348933